Mary A. Simmonds

1.3k total citations
37 papers, 999 citations indexed

About

Mary A. Simmonds is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mary A. Simmonds has authored 37 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Mary A. Simmonds's work include Pain Management and Opioid Use (7 papers), Prostate Cancer Treatment and Research (6 papers) and Cancer Treatment and Pharmacology (5 papers). Mary A. Simmonds is often cited by papers focused on Pain Management and Opioid Use (7 papers), Prostate Cancer Treatment and Research (6 papers) and Cancer Treatment and Pharmacology (5 papers). Mary A. Simmonds collaborates with scholars based in United States, India and United Kingdom. Mary A. Simmonds's co-authors include Allan Lipton, Harold A. Harvey, Peter S. Houts, Paul Coluzzi, M. A. Busch, Russell K. Portenoy, Mary J. Bartholomew, Alice E. Boucher, Robert Gordon and Earl Nordbrock and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mary A. Simmonds

36 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary A. Simmonds United States 15 271 264 245 160 141 37 999
I. Krakowski France 18 139 0.5× 676 2.6× 145 0.6× 619 3.9× 151 1.1× 108 1.5k
Miguel Ángel Álvarez-Avitia Mexico 16 158 0.6× 124 0.5× 95 0.4× 218 1.4× 164 1.2× 43 1.0k
Richard J. Rosenbluth United States 16 48 0.2× 386 1.5× 90 0.4× 134 0.8× 151 1.1× 26 945
Daniela Polastri Italy 16 197 0.7× 137 0.5× 297 1.2× 244 1.5× 154 1.1× 35 872
Fausto Roila Italy 15 126 0.5× 336 1.3× 176 0.7× 176 1.1× 163 1.2× 44 800
Susan N. Rosenthal United States 20 63 0.2× 311 1.2× 100 0.4× 156 1.0× 206 1.5× 30 1.2k
Fabrizio Artioli Italy 18 93 0.3× 497 1.9× 144 0.6× 358 2.2× 133 0.9× 49 966
T.J. Priestman United Kingdom 20 51 0.2× 580 2.2× 151 0.6× 349 2.2× 376 2.7× 35 1.3k
Deirdre R. Pachman United States 18 100 0.4× 951 3.6× 107 0.4× 180 1.1× 109 0.8× 49 1.3k
Francesco Rosetti Italy 13 74 0.3× 640 2.4× 117 0.5× 437 2.7× 139 1.0× 23 1.1k

Countries citing papers authored by Mary A. Simmonds

Since Specialization
Citations

This map shows the geographic impact of Mary A. Simmonds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary A. Simmonds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary A. Simmonds more than expected).

Fields of papers citing papers by Mary A. Simmonds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary A. Simmonds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary A. Simmonds. The network helps show where Mary A. Simmonds may publish in the future.

Co-authorship network of co-authors of Mary A. Simmonds

This figure shows the co-authorship network connecting the top 25 collaborators of Mary A. Simmonds. A scholar is included among the top collaborators of Mary A. Simmonds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary A. Simmonds. Mary A. Simmonds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Payne, Richard, Paul Coluzzi, Lowell L. Hart, et al.. (2001). Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain. Journal of Pain and Symptom Management. 22(1). 575–583. 76 indexed citations
2.
Simmonds, Mary A.. (1999). Management of breakthrough pain due to cancer.. PubMed. 13(8). 1103–8; discussion 1110, 1113. 42 indexed citations
3.
Christie, Joan M., Mary A. Simmonds, Richard B. Patt, et al.. (1998). Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.. Journal of Clinical Oncology. 16(10). 3238–3245. 131 indexed citations
4.
Stevenson, James, Richard M. Scher, Mary A. Simmonds, et al.. (1998). Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas. European Journal of Cancer. 34(9). 1358–1362. 18 indexed citations
5.
Simmonds, Mary A.. (1995). Transdermal fentanyl: clinical development in the United States. Anti-Cancer Drugs. 6(Supplement 3). 35–38. 10 indexed citations
6.
Houts, Peter S., et al.. (1991). Information needs of families of cancer patients: A literature review and recommendations. Journal of Cancer Education. 6(4). 255–261. 59 indexed citations
7.
Houts, Peter S., et al.. (1991). Using a state cancer registry to increase screening behaviors of sisters and daughters of breast cancer patients.. American Journal of Public Health. 81(3). 386–388. 32 indexed citations
8.
Manni, Andrea, Alice E. Boucher, Laurence M. Demers, et al.. (1990). Somatostatin analogues in the treatment of breast and prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 1083–1087. 13 indexed citations
9.
Manni, Andrea, Alice E. Boucher, L. M. Demers, et al.. (1989). Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer. Breast Cancer Research and Treatment. 14(3). 289–298. 56 indexed citations
10.
Santen, Richard J., Steven J. Santner, Harold A. Harvey, et al.. (1988). Marked heterogeneity of aromatase activity in human malignant melanoma tissue. European Journal of Cancer and Clinical Oncology. 24(12). 1811–1816. 10 indexed citations
11.
Lipton, Allan, et al.. (1988). A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy.. PubMed. 7(3). 309–17. 7 indexed citations
12.
Simmonds, Mary A., et al.. (1988). A new approach to the administration of opiates: TTS (fentanyl) in the management of pain in patients with cancer. Journal of Pain and Symptom Management. 3. S18–S18. 10 indexed citations
13.
Manni, Andrea, Alice E. Boucher, Allan Lipton, et al.. (1987). Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer. Journal of Steroid Biochemistry. 27(1-3). 551–556. 8 indexed citations
14.
Grunwald, Gerald B., Steven E. Kornguth, Javad Towfighi, et al.. (1987). Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells. Cancer. 60(4). 780–786. 59 indexed citations
15.
Lipton, Allan, et al.. (1985). A phase II study of Catrix-S in solid tumors.. PubMed. 4(6). 585–9. 2 indexed citations
16.
Manni, Andrea, Richard J. Santen, Alice E. Boucher, et al.. (1985). Hormone stimulation and chemotherapy in advanced prostate cancer: preliminary results of a prospective controlled clinical trial.. PubMed. 5(2). 161–5. 10 indexed citations
17.
Harvey, Harold A., et al.. (1984). Symptomatic Malignant Melanoma of the Gastrointestinal Tract. Annals of Surgery. 199(3). 328–331. 35 indexed citations
18.
Harvey, Harold A., Allan Lipton, & Mary A. Simmonds. (1982). A randomized trial of Alkeran versus cyclophosphamide, hexamethylmelamine, adriamycin and cis-platinum combination chemotherapy in advanced ovarian carcinoma. Clinical research. 30(2). 1 indexed citations
19.
Simmonds, Mary A., Allan Lipton, & Harold A. Harvey. (1981). FAC vs. L-PAM chemotherapy for adjuvant treatment of breast cancer in post-menopausal women. Proceedings of the American Association for Cancer Research. 22. 1 indexed citations
20.
Simmonds, Mary A., et al.. (1981). Chronic Lymphocytic Leukemia Cells Lack the 185,000-Dalton Macromolecular Insoluble Cold Globulin Present on Normal B Lymphocytes. Journal of Clinical Investigation. 67(3). 624–631. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. Krakowski Breakdown of academic impact, for papers by Miguel Ángel Álvarez-Avitia Breakdown of academic impact, for papers by Richard J. Rosenbluth Breakdown of academic impact, for papers by Daniela Polastri Breakdown of academic impact, for papers by Fausto Roila Breakdown of academic impact, for papers by Susan N. Rosenthal Breakdown of academic impact, for papers by Fabrizio Artioli Breakdown of academic impact, for papers by T.J. Priestman Breakdown of academic impact, for papers by Deirdre R. Pachman Breakdown of academic impact, for papers by Francesco Rosetti
Rankless by CCL
2026